captopril has been researched along with Breast Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseini, A; Jaberipour, M; Namazi, S; Razmkhah, M; Rostami-Yalmeh, J; Sahebi, E | 1 |
| Amore, C; Cugino, D; Cutrone, A; de Gaetano, G; Di Santo, A; Donati, MB; Iacoviello, L; Lorenzet, R; Napoleone, E | 1 |
| García Rodríguez, LA; González-Pérez, A; Ronquist, G | 1 |
| Blasick, TM; Brown, RE; Lun, M; Prichard, JW; Zhang, PL | 1 |
| Boiskin, M; Bruera, E; Fainsinger, R; Schoeller, T | 1 |
| Chen, Z; Kim, YT; Molteni, A; Small, W; Taylor, JM; Ward, WF | 1 |
| Kim, YT; Molteni, A; Small, W; Taylor, JM; Ts'ao, CH; Ward, WF | 1 |
7 other study(ies) available for captopril and Breast Neoplasms
| Article | Year |
|---|---|
The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: an in vitro study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Captopril; Cell Proliferation; Cell Shape; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Losartan; MCF-7 Cells; Remission Induction; Renin-Angiotensin System; RNA, Messenger; Tamoxifen | 2014 |
Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
Topics: Adenocarcinoma; Angiotensin-Converting Enzyme Inhibitors; Breast Neoplasms; Captopril; Cell Line, Tumor; Down-Regulation; Enalapril; Female; Humans; MCF-7 Cells; Neovascularization, Pathologic; Renin-Angiotensin System; Thromboplastin; Vascular Endothelial Growth Factor A | 2012 |
Breast cancer incidence and use of antihypertensive medication in women.
Topics: Adult; Age Distribution; Aged; Antihypertensive Agents; Breast Neoplasms; Captopril; Case-Control Studies; Female; Humans; Incidence; Logistic Models; Medical Records Systems, Computerized; Middle Aged; Registries; United Kingdom | 2004 |
Morphoproteomic and pharmacoproteomic correlates in hormone-receptor-negative breast carcinoma cell lines.
Topics: Antineoplastic Agents; Benzamides; Breast Neoplasms; Captopril; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Hormones; Humans; Imatinib Mesylate; Immunohistochemistry; Interferon-alpha; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Piperazines; Proteomics; Pyrimidines; Receptors, Cell Surface | 2004 |
Palliative care round: cognitive failure and coma after renal failure in a patient receiving captopril and hydromorphone.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Captopril; Cognition Disorders; Coma; Female; Humans; Hydromorphone; Hypertension; Kidney Failure, Chronic; Pain | 1993 |
Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Breast Neoplasms; Captopril; Carcinoma, Ductal, Breast; Cell Division; Female; Humans; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1997 |
Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Captopril; Carcinoma, Ductal, Breast; Copper; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydrogen Peroxide; Lisinopril; Penicillamine; Tumor Cells, Cultured | 1999 |